Notably, in patients with AD accompanied by past stroke lesions, plasma GFAP levels may be associated with the severity of cognitive impairment, and plasma NfL levels may reflect the severity of delusions as neuropsychological symptoms. This evidence concerns the gene NEFL and Cognitive impairment.